| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 25 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $411.0K | - | |
| CFO | 26.0K | $178.1K | - | |
| Dir | 7.0K | $48.0K | - | |
| Dir | 7.0K | $48.0K | - | |
| Dir | 7.0K | $48.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $42.19 | $1,630,208.52 | -0.2% | |
| Dec 14, 2017 | Yu K Peony | Chief Medical Officer | Sell | 2,851 | $43.70 | $124,588.70 | -1.7% | |
| Dec 12, 2017 | Kurkijarvi Kalevi | Director | Sale+OE | 12,000 | $44.45 | $533,400.00 | -33.3% | |
| Dec 11, 2017 | Cotroneo Pat | VP, Finance And CFO | Sell | 2,851 | $46.00 | $131,146.00 | -1.5% | |
| Dec 4, 2017 | Lema Gerald | Director | Buy | 3,500 | $46.70 | $163,450.00 | New | |
| Dec 1, 2017 | Routti Jorma | Director | Sale+OE | 12,000 | $47.25 | $567,000.00 | -4.5% | |
| Nov 17, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $46.65 | $93,300.00 | -7.7% | |
| Nov 17, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $46.63 | $1,801,638.00 | -0.2% | |
| Nov 15, 2017 | Kearns Thomas F Jr | Director | Sale+OE | 18,000 | $45.22 | $813,960.00 | -11.5% | |
| Nov 6, 2017 | Yu K Peony | Chief Medical Officer | Sell | 7,500 | $55.37 | $415,243.50 | -2.2% |